Phil Ferneau

Phil Ferneau has a long history of work experience in venture capital and investments. Phil began their career in 2002 as Co-Founder and Managing Partner of Borealis Ventures. Phil then went on to become an Investor in Adimab in 2008. Phil was a Board Observer and Investor for Teckro in 2018, and a Board Director and Investor for Orbit Discovery, Ovation.io, Amagma Therapeutics, T-Cypher Bio, and Ankyra Therapeutics between 2018 and 2021. Phil was also an Investor for Evox Therapeutics Ltd in 2018.

Phil Ferneau holds an MBA from The Tuck School of Business at Dartmouth, an A.B. in Government from Dartmouth College, and a J.D. from the University of Virginia School of Law.